SUMSearch 2

Original studies

Systematic reviews

Guidelines

 
37 found after 6 searches:
1. Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability.
JAMA 2024;331:14. PMID: 38592388 , PubMed Central, doi: 10.1001/jama.2024.3172, Cited by. Cite
Conclusion: regnancy was not associated with children's risk of autism, ADHD, or intellectual disability in sibling control analysis. This suggests that associations observed in other models may have been attributable to familial confounding.
Impact/quality: Governmental/foundation support *
2. ADHD Pharmacotherapy and Mortality in Individuals With ADHD.
JAMA 2024;331:10. PMID: 38470385 , PubMed Central, doi: 10.1001/jama.2024.0851, Cited by. Cite
Conclusion: d with ADHD, medication initiation was associated with significantly lower all-cause mortality, particularly for death due to unnatural causes.
Impact/quality: Accompanied by editorial; *
3. Trial of Training to Reduce Driver Inattention in Teens with ADHD.
N Engl J Med 2022;387:22. PMID: 36449421 , PubMed Central, doi: 10.1056/NEJMoa2204783, Cited by. Cite
Conclusion: ially designed computerized simulated-driving program with feedback to reduce long glances away from the roadway reduced the frequency of long glances and lessened variation in lane position as compared with a control program. During real-world driving in the year after training, the rate of collisions and near-collisions was lower in the intervention group. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT02848092.).
Impact/quality: Governmental/foundation support *
4. α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.
JAMA 2021;325:20. PMID: 33946100 , PubMed Central, doi: 10.1001/jama.2021.6118, Cited by. Cite
Conclusion: ew of health records of preschool-age children with ADHD treated in developmental-behavioral pediatric practices, improvement was noted in the majority of children who received α2-adrenergic agonists or stimulants, with differing adverse effect profiles between medication classes. Further research, including from randomized clinical trials, is needed to assess comparative effectiveness of α2-adrenergic agonists vs stimulants.
Impact/quality: Accompanied by editorial; *
5. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
N Engl J Med 2019;380:12. PMID: 30893533 , PubMed Central, doi: 10.1056/NEJMoa1813751, Cited by. Cite
Conclusion: g adults with ADHD who were receiving prescription stimulants, new-onset psychosis occurred in approximately 1 in 660 patients. Amphetamine use was associated with a greater risk of psychosis than methylphenidate. (Funded by the National Institute of Mental Health and others.).
Impact/quality: Accompanied by editorial; * Governmental/foundation support *
6. Attention Deficit-Hyperactivity Disorder and Month of School Enrollment.
N Engl J Med 2018;379:22. PMID: 30485780 , PubMed Central, doi: 10.1056/NEJMoa1806828, Cited by. Cite
Conclusion: atment of ADHD are higher among children born in August than among children born in September in states with a September 1 cutoff for kindergarten entry. (Funded by the National Institutes of Health.).
Impact/quality: Governmental/foundation support *
7. Association of Digital Media Use With Subsequent Symptoms of Attention-Deficit/Hyperactivity Disorder Among Adolescents.
JAMA 2018;320:3. PMID: 30027248 , PubMed Central, doi: 10.1001/jama.2018.8931, Cited by. Cite
Conclusion: up over 2 years, there was a statistically significant but modest association between higher frequency of digital media use and subsequent symptoms of ADHD. Further research is needed to determine whether this association is causal.
Impact/quality: Accompanied by editorial; * Governmental/foundation support *
8. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.
BMJ 2017;357:. PMID: 28566274 , PubMed Central, doi: 10.1136/bmj.j2350, Cited by. Cite
Conclusion: Sibling matched analysis identified no significant difference in risk of ADHD in siblings exposed to antidepressants during gestation and those not exposed during gestation (0.54, 0.17 to 1.74, P=0.30).Conclusions The findings suggest that the association between prenatal use of antidepressants and risk of ADHD in offspring can be partially explained by confounding by indication of antidepressants. If there is a causal association, the size of the effect is probably smaller than that reported previously.
9. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
JAMA 2017;317:15. PMID: 28418479 , PubMed Central, doi: 10.1001/jama.2017.3413, Cited by. Cite
Conclusion: eden, after accounting for confounding factors, first-trimester exposure to antidepressants, compared with no exposure, was associated with a small increased risk of preterm birth but no increased risk of small for gestational age, autism spectrum disorder, or attention-deficit/hyperactivity disorder.
Impact/quality: Accompanied by editorial; * Governmental/foundation support *
10. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study.
BMJ 2016;353:. PMID: 27245699 , PubMed Central, doi: 10.1136/bmj.i2550, Cited by. Cite
Conclusion:  The relative risk of myocardial infarction and arrhythmias is increased in the early period after the start of methylphenidate treatment for ADHD in children and young people. Though the absolute risk is likely to be low, the risk-benefit balance of methylphenidate should be carefully considered, particularly in children with mild ADHD.
11. Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
JAMA 2016;315:18. PMID: 27163989 , doi: 10.1001/jama.2016.3611, Cited by. Cite
Conclusion: Is treatment with methylphenidate associated with benefits or harms for children and adolescents with attention-deficit/hyperactivity disorder (ADHD)?
Impact/quality: Accompanied by editorial; *
12. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study.
Lancet 2015;385:9983. PMID: 25726514 , doi: 10.1016/S0140-6736(14)61684-6, Cited by. Cite
Conclusion: ADHD was associated with significantly increased mortality rates. People diagnosed with ADHD in adulthood had a higher MRR than did those diagnosed in childhood and adolescence. Comorbid oppositional defiant disorder, conduct disorder, and substance use disorder increased the MRR even further. However, when adjusted for these comorbidities, ADHD remained associated with excess mortality, with higher MRRs in girls and women with ADHD than in boys and men with ADHD. The excess mortality in ADHD was mainly driven by deaths from unnatural causes, especially accidents.
Impact/quality: Accompanied by editorial; *
13. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.
BMJ 2015;350:. PMID: 25646809 , PubMed Central, doi: 10.1136/bmj.h68, Cited by. Cite
Conclusion: A brief behavioural sleep intervention modestly improves the severity of ADHD symptoms in a community sample of children with ADHD, most of whom were taking stimulant medications. The intervention also improved the children's sleep, behaviour, quality of life, and functioning, with most benefits sustained to six months post-intervention. The intervention may be suitable for use in primary and secondary care.Trial registration Current Controlled Trials ISRCTN68819261.
14. Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study.
BMJ 2014;348:. PMID: 24942388 , PubMed Central, doi: 10.1136/bmj.g3769, Cited by. Cite
Conclusion: This study found no evidence for a positive association between the use of drug treatments for ADHD and the risk of concomitant suicidal behaviour among patients with ADHD. If anything, the results pointed to a potential protective effect of drugs for ADHD on suicidal behaviour, particularly for stimulant drugs. The study highlights the importance of using within patient designs to control for confounding in future pharmacoepidemiological studies.
15. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
Lancet 2013;381:9875. PMID: 23453885 , PubMed Central, doi: 10.1016/S0140-6736(12)62129-1, Cited by. Cite
Conclusion: Our findings show that specific SNPs are associated with a range of psychiatric disorders of childhood onset or adult onset. In particular, variation in calcium-channel activity genes seems to have pleiotropic effects on psychopathology. These results provide evidence relevant to the goal of moving beyond descriptive syndromes in psychiatry, and towards a nosology informed by disease cause.
Impact/quality: Accompanied by editorial; * Governmental/foundation support *
16. Medication for attention deficit-hyperactivity disorder and criminality.
N Engl J Med 2012;367:21. PMID: 23171097 , PubMed Central, doi: 10.1056/NEJMoa1203241, Cited by. Cite
Conclusion: Among patients with ADHD, rates of criminality were lower during periods when they were receiving ADHD medication. These findings raise the possibility that the use of medication reduces the risk of criminality among patients with ADHD. (Funded by the Swedish Research Council and others.).
Impact/quality: Governmental/foundation support *
17. Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study.
BMJ 2012;345:. PMID: 22809800 , PubMed Central, doi: 10.1136/bmj.e4627, Cited by. Cite
Conclusion: Treatment of children with central nervous stimulants is not significantly associated with an increase in the short term risk of severe cardiac events. Analyses cannot be generalised to children with long term use of stimulants. Furthermore, long term effects of slight increases in heart rate or blood pressure are unknown.
Impact/quality: Governmental/foundation support *
18. ADHD drugs and serious cardiovascular events in children and young adults.
N Engl J Med 2011;365:20. PMID: 22043968 , PubMed Central, doi: 10.1056/NEJMoa1110212, Cited by. Cite
Conclusion: This large study showed no evidence that current use of an ADHD drug was associated with an increased risk of serious cardiovascular events, although the upper limit of the 95% confidence interval indicated that a doubling of the risk could not be ruled out. However, the absolute magnitude of such an increased risk would be low. (Funded by the Agency for Healthcare Research and Quality and the Food and Drug Administration.).
Impact/quality: Governmental/foundation support * Evid Based Ment Health. 2012 May;15(2):43; **
19. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial.
Lancet 2011;377:9764. PMID: 21296237 , doi: 10.1016/S0140-6736(10)62227-1, Cited by. Cite
Conclusion: A strictly supervised restricted elimination diet is a valuable instrument to assess whether ADHD is induced by food. The prescription of diets on the basis of IgG blood tests should be discouraged.
Impact/quality: Accompanied by editorial; *
20. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis.
Lancet 2010;376:9750. PMID: 20888040 , PubMed Central, doi: 10.1016/S0140-6736(10)61109-9, Cited by. Cite
Conclusion: Our findings provide genetic evidence of an increased rate of large CNVs in individuals with ADHD and suggest that ADHD is not purely a social construct.
Impact/quality: Accompanied by editorial; editorial; * Governmental/foundation support *
21. Early head injury and attention deficit hyperactivity disorder: retrospective cohort study.
BMJ 2008;337:. PMID: 18988644 , PubMed Central, doi: 10.1136/bmj.a1984, Cited by. Cite
Conclusion: To explore the hypothesis that medically attended head injury in young children may be causal in the later development of attention deficit hyperactivity disorder.
22. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial.
JAMA 2008;299:22. PMID: 18544723 , PubMed Central, doi: 10.1001/jama.299.22.2633, Cited by. Cite
Conclusion: In this study, use of H. perforatum for treatment of ADHD over the course of 8 weeks did not improve symptoms.
Impact/quality: Accompanied by editorial; * Governmental/foundation support *
23. Hyperactivity in children: the Gillberg affair.
BMJ 2007;335:7616. PMID: 17717364 , PubMed Central, doi: 10.1136/bmj.39304.486146.AD, Cited by. Cite
Conclusion: What drove members of a highly respected psychiatric research group to defy the Swedish courts and destroy 15 years' worth of irreplaceable data? A decade after the Gillberg affair began, Jonathan Gornall examines the facts
24. Use of stimulants for attention deficit hyperactivity disorder: AGAINST.
BMJ 2004;329:7471. PMID: 15485976 , PubMed Central, doi: 10.1136/bmj.329.7471.908, Cited by. Cite
Conclusion: Definitive diagnosis of attention deficit hyperactivity disorder is complex. David Coghill believes the condition is undertreated, but Harvey Markovitch argues that current uncertainties about diagnosis and treatment mean doctors should be cautious
25. Use of stimulants for attention deficit hyperactivity disorder: FOR.
BMJ 2004;329:7471. PMID: 15485975 , PubMed Central, doi: 10.1136/bmj.329.7471.907, Cited by. Cite
Conclusion: Definitive diagnosis of attention deficit hyperactivity disorder is complex. David Coghill believes the condition is undertreated, but Harvey Markovitch argues that current uncertainties about diagnosis and treatment mean doctors should be cautious
Impact/quality: Accompanied by editorial; *
26. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder.
Lancet 2003;362:9397. PMID: 14643117 , doi: 10.1016/S0140-6736(03)14842-8, Cited by. Cite
Conclusion: The frontal, temporal, and parietal regions are heteromodal association cortices that constitute a distributed neural system, which subserves attention and behavioural inhibition. We have identified region-specific anatomical abnormalities in cortical components of attentional systems, which may help better account for the symptoms of attention-deficit hyperactivity disorder.
Impact/quality: Governmental/foundation support *
27. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.
JAMA 2002;288:14. PMID: 12365958 , doi: 10.1001/jama.288.14.1740, Cited by. Cite
Conclusion: Developmental trajectories for all structures, except caudate, remain roughly parallel for patients and controls during childhood and adolescence, suggesting that genetic and/or early environmental influences on brain development in ADHD are fixed, nonprogressive, and unrelated to stimulant treatment.
28. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder.
JAMA 2001;285:1. PMID: 11150110 , doi: 10.1001/jama.285.1.60, Cited by. Cite
Conclusion: In our cohort, compared with persons without ADHD, those with ADHD exhibited substantially greater use of medical care in multiple care delivery settings.
Impact/quality: Governmental/foundation support *
29. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone.
N Engl J Med 1993;328:14. PMID: 8450877 , doi: 10.1056/NEJM199304083281403, Cited by. Cite
Conclusion: In our study sample, attention deficit-hyperactivity disorder is strongly associated with generalized resistance to thyroid hormone.
Impact/quality: Accompanied by editorial; *
30. Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome.
Lancet 1992;339:8802. PMID: 1349376 , doi: 10.1016/0140-6736(92)90742-l, Cited by. Cite
Conclusion: Our results show that EPD permits children with food-induced hyperkinetic syndrome to eat foods that had previously been identified as responsible for their symptoms. These results also support the notion that food allergy is a possible mechanism of the hyperkinetic syndrome.
31. Cerebral glucose metabolism in adults with hyperactivity of childhood onset.
N Engl J Med 1990;323:20. PMID: 2233902 , doi: 10.1056/NEJM199011153232001, Cited by. Cite
Conclusion: Glucose metabolism, both global and regional, was reduced in adults who had been hyperactive since childhood. The largest reductions were in the premotor cortex and the superior prefrontal cortex--areas earlier shown to be involved in the control of attention and motor activity.
Impact/quality: Accompanied by editorial; *
32. Focal cerebral dysfunction in developmental learning disabilities.
Lancet 1990;335:8680. PMID: 1967380 , doi: 10.1016/0140-6736(90)90136-s, Cited by. Cite
Conclusion: Low activity in striatal and posterior periventricular areas was also seen in the 8 children with ADHD in combination with phonologic-syntactic dysphasia. 7 children with dysphasia, but without hyperactive behaviour, had low cerebral activity in left temporofrontal regions.
33. A survey of medication treatment for hyperactive/inattentive students.
JAMA 1988;260:15. PMID: 2902237 , Cited by. Cite
Conclusion: Since 1971, the Baltimore County Health Department has conducted nine biannual surveys of school nurses in all of the county's public and private schools to determine the prevalence of medication treatment for hyperactivity/inattentiveness among students. The results reveal a consistent doubling of the rate of medication treatment for hyperactive/inattentive students every four to seven years such that in 1987, 5.96% of all public elementary school students were receiving such treatment. Related trends from 1971 to 1987 have been that stimulants increased from 76% to 99% of the medication prescribed; methylphenidate hydrochloride rose from 40% to 93% of the total; the male-female ratio dropped from an average of 8:1 to 5:1; the rate of medication treatment for hyperactive/inattentive students rose faster in secondary than in elementary schools; and 25% of students receiving stimulant medication in 1987 were in special education classes or schools.
34. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome.
Lancet 1985;1:8428. PMID: 2857900 , doi: 10.1016/s0140-6736(85)91206-1, Cited by. Cite
Conclusion: 48 foods were incriminated. Artificial colorants and preservatives were the commonest provoking substances, but no child was sensitive to these alone.
35. Stimulant medications precipitate Tourette's syndrome.
JAMA 1982;247:8. PMID: 6120250 , Cited by. Cite
Conclusion: In these Tourette's-susceptible patients, stimulants may exacerbate severe motor and phonic tics, requiring discontinuation of administration of stimulants and institution of haloperidol therapy for tic control. Clinical evaluation for tics and Tourette's syndrome in children and their families should precede and dictate use of stimulant medications in children.
Impact/quality: Governmental/foundation support *
36. Megavitamins for minimal brain dysfunction. A placebo-controlled study.
JAMA 1978;240:24. PMID: 712981 , Cited by. Cite
Conclusion: Preliminary to a stimulant comparison study, 31 children with minimal brain dysfunction randomly received either placebo or a megavitamin combination. During a two-week trial, only two children responded so well that stiumlants were not considered necessary; both were in the placebo group. Change scores from pretest to posttest on four blind ratings by teachers and parents did not show a significant difference between the placebo and vitamin groups.
37. Megavitamins for minimal brain dysfunction. A potentially dangerous therapy.
JAMA 1977;238:16. PMID: 578271 , Cited by. Cite
Conclusion: Vitamin A intoxication as a consequence of megavitamin therapy for minimal brain dysfunction occurred in a 4-year-old boy. An early clue to diagnosis was provided by an abnormal bone scan.
Show evidence search details (access to earlier iterations If results displayed are too restrictive)
 
 
Monday, 20 May 2024 05:40:53 at SUMSearch
 
Questions: rbadgett@kumc.edu